Kiniksa Pharmaceuticals International, plc (KNSA) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 02/17/26
Kiniksa Pharmaceuticals International, plc (KNSA) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/07/26
Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in LondonGlobeNewsWire • 11/12/25
Kiniksa: How Category Ownership And Higher Duration Are Translating Into Operating LeverageSeeking Alpha • 10/30/25
Kiniksa Pharmaceuticals International, plc (KNSA) Q3 2025 Earnings Call TranscriptSeeking Alpha • 10/28/25
Kiniksa Pharmaceuticals International, plc (KNSA) Q3 Earnings Miss EstimatesZacks Investment Research • 10/28/25
Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio ExecutionGlobeNewsWire • 10/28/25
Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025GlobeNewsWire • 10/23/25
Kiniksa Pharmaceuticals Announces U.S. Orphan Drug Designation for KPL-387 for the Treatment of PericarditisGlobeNewsWire • 10/17/25
Why Kiniksa Pharmaceuticals International, plc (KNSA) is Poised to Beat Earnings Estimates AgainZacks Investment Research • 10/16/25
Wall Street Analysts Think Kiniksa Pharmaceuticals International, plc (KNSA) Could Surge 29.3%: Read This Before Placing a BetZacks Investment Research • 10/14/25
Kiniksa Pharmaceuticals International, plc (KNSA) is on the Move, Here's Why the Trend Could be SustainableZacks Investment Research • 09/19/25
Kiniksa Pharmaceuticals International, Plc (KNSA) Presents At Citi's Biopharma Back To School Conference TranscriptSeeking Alpha • 09/03/25
Court Ruling & Tariff Uncertainty: Time to Bet on POST, TME & KNSA?Zacks Investment Research • 09/02/25
Wall Street Analysts Believe Kiniksa Pharmaceuticals International, plc (KNSA) Could Rally 26.69%: Here's is How to TradeZacks Investment Research • 08/18/25
5 Stocks With Recent Price Strength Amid Trade & Rate Cut UncertaintiesZacks Investment Research • 08/13/25
Kiniksa Pharmaceuticals International, plc (KNSA) Is Up 21.46% in One Week: What You Should KnowZacks Investment Research • 08/05/25
Just The Tonic: This Medical Stock, A Mutual Fund Darling, Tests Entry Amid 58% RunInvestors Business Daily • 08/01/25
Why Kiniksa Pharmaceuticals International, plc (KNSA) Might be Well Poised for a SurgeZacks Investment Research • 08/01/25
Does Kiniksa Pharmaceuticals International, plc (KNSA) Have the Potential to Rally 35.96% as Wall Street Analysts Expect?Zacks Investment Research • 08/01/25
Kiniksa Pharmaceuticals International, plc (KNSA) Q2 2025 Earnings Call TranscriptSeeking Alpha • 07/29/25